As the world’s second largest populated country, India presents unmatched opportunities for businesses in life sciences and healthcare sector, with a fair share of regulatory and enforcement issues. Today pharmaceutical, medical devices and biotech companies are looking at opportunities for manufacturing, marketing, distribution, collaboration and other alliances in India. The contribution of India in the drug discovery process shortening time-to-market is significant, interspersed with occasional debates concerning conduct of widespread clinical trials.
The Firm also advises on agricultural biotechnology including regulatory and licensing approvals for import, export, transportation and handling of hybrid and transgenic seeds, genetically engineered organisms and cells and conduct of field trials.
Members of the Firm advise ethics committees, and have been members of reputed independent and institutional ethics committees.